Variations in IDH2, which encodes an IDH involved in cellular energy metabolism and oxidative stress responses, may affect cellular metabolic and immunoregulatory pathways, leading to alterations in the tumor microenvironment, which in turn affects CD8+ T cell infiltration [77, 78]. The gene discussed is IDH2; the disease is neoplasm.